āĻĒā§āϰāϝ⧁āĻ•ā§āϤāĻŋāĻ—āϤ āĻ—āĻžāχāĻĄ

TRIPOD+AI and CONSORT-AI Reporting Guidelines

TRIPOD+AI and CONSORT-AI are reporting guidelines that help researchers describe prediction-model studies and clinical trials involving AI.

āĻāχ āύāĻŋāĻ°ā§āĻĻ⧇āĻļāĻŋāĻ•āĻž āĻļ⧁āύ⧁āύāĻāφāχ-āĻŦāĻ°ā§āĻŖāĻŋāϤ ¡ ~3 min

āĻāχ āĻĒ⧃āĻˇā§āĻ āĻžāϝāĻŧ3 āĻŽāĻŋāύāĻŋāϟ āĻĒāĻĄāĻŧāĻž āĻšāϝāĻŧ⧇āϛ⧇
  1. āĻ“āĻ­āĻžāϰāĻ­āĻŋāω
  2. āĻ—āĻ­ā§€āϰ āĻĄā§āĻŦ
  3. āĻŦāĻžāĻ¸ā§āϤāĻŦ-āĻŦāĻŋāĻļā§āĻŦ āĻŦāĻžāĻ¸ā§āϤāĻŦāĻžāϝāĻŧāύ
  4. The Future of TRIPOD+AI and CONSORT-AI Reporting Guidelines
  5. āĻāϟāĻžāϕ⧇ āĻŦāĻžāĻ¸ā§āϤāĻŦ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāĻž āĻšāĻšā§āϛ⧇
  6. āĻ…āĻ¨ā§āĻŦ⧇āώāĻŖ āϚāĻžāϞāĻŋāϝāĻŧ⧇ āϝāĻžāύ
  7. āĻĒā§āϰāĻžāϝāĻŧāĻļāχ āϜāĻŋāĻœā§āĻžāĻžāϏāĻŋāϤ āĻĒā§āϰāĻļā§āύāĻžāĻŦāϞ⧀

āĻ“āĻ­āĻžāϰāĻ­āĻŋāω

They improve transparency and interpretability but do not certify study quality or prove a model is safe. Authors should match the guideline to study design and report intended use, data, methods, and AI-specific details.

āĻ—āĻ­ā§€āϰ āĻĄā§āĻŦ

Reporting guidelines provide structured items authors should include so readers can understand how a study was designed and what it found. TRIPOD+AI updates reporting for clinical prediction models developed with regression or machine learning. CONSORT-AI extends CONSORT for randomized clinical trials evaluating interventions that include AI. These guides serve different study designs and do not replace one another. TRIPOD+AI supports complete reporting of prediction model development and evaluation, including participants, data sources, predictors, outcome definitions, model methods, validation, and performance. CONSORT-AI adds trial-specific details about the AI intervention, how it was used, human-AI interaction, and implementation. A checklist helps identify missing information but cannot repair a biased design, an unrepresentative sample, or an inappropriate analysis. Authors should select the guideline that fits the study and report the AI system’s intended role, version, inputs, workflow, data handling, and limitations. Editors and reviewers can use the checklists to assess transparency and reproducibility. Readers should still evaluate methods, risk of bias, and applicability to practice. Reporting quality is necessary for interpretation but is not evidence by itself that a model is safe or effective. Readers should check whether claims are consistent with the methods, whether validation data are independent, and whether limitations are reported. Transparent reporting makes it possible to identify missing details but cannot compensate for weak study design or inappropriate interpretation.

āĻŦāĻžāĻ¸ā§āϤāĻŦ-āĻŦāĻŋāĻļā§āĻŦ āĻŦāĻžāĻ¸ā§āϤāĻŦāĻžāϝāĻŧāύ

A model-development paper uses TRIPOD+AI items to describe participants, predictors, and validation.

A randomized trial report follows CONSORT-AI to explain the intervention and participant flow.

A reviewer checks whether model thresholds and missing-data handling are reported.

A research team distinguishes a reporting checklist from a risk-of-bias assessment.

The Future of TRIPOD+AI and CONSORT-AI Reporting Guidelines

As AI studies diversify, reporting standards may expand to new models and settings. Researchers should use current versions and companion guidance, and journals can request completed checklists. Better reporting supports replication and critical appraisal, but sound design, adequate validation, and fair interpretation remain essential. Guidelines are aids to transparency, not endorsements of a model. Journals and funders may update expectations as guideline versions evolve. Researchers can use reporting items early in protocol planning to ensure data collection supports complete reporting later.

āĻāϟāĻžāϕ⧇ āĻŦāĻžāĻ¸ā§āϤāĻŦ⧇ āĻĒā§āϰāϝāĻŧā§‹āĻ— āĻ•āϰāĻž āĻšāĻšā§āϛ⧇

āϕ⧇āύ āĻāϟāĻž āϗ⧁āϰ⧁āĻ¤ā§āĻŦāĻĒā§‚āĻ°ā§āĻŖ

  • āĻ–āϰāϚ āĻ“ āĻŦāĻžāĻœā§‡āϟ. āφāĻ°ā§āĻ•āĻŋāĻŸā§‡āĻ•āϚāĻžāϰ⧇āϰ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤāϗ⧁āϞāĻŋ āĻŦāĻ›āϰ⧇āϰ āĻĒāϰ āĻŦāĻ›āϰ āϧāϰ⧇ āĻ•āĻ°ā§āĻŽāĻ•ā§āώāĻŽāϤāĻž āĻāĻŦāĻ‚ āĻ…āĻĒāĻžāϰ⧇āϟāĻŋāĻ‚ āĻ–āϰāϚ āϚāĻžāϞāĻžāϝāĻŧāĨ¤
  • āϏ⧁āĻ¸ā§āĻĒāĻˇā§āϟ āϏāĻŋāĻĻā§āϧāĻžāĻ¨ā§āϤ. āĻ•āĻžāϰāĻŋāĻ—āϰāĻŋ āĻļāĻŋāĻ•ā§āώāĻž āĻĻāϞāϗ⧁āϞ⧋āϕ⧇ āϏāĻ āĻŋāĻ• āĻ¸ā§āĻŸā§āϝāĻžāĻ• āĻŦ⧇āϛ⧇ āύāĻŋāϤ⧇ āϏāĻžāĻšāĻžāĻ¯ā§āϝ āĻ•āϰ⧇, āĻļ⧁āϧ⧁ āύāϤ⧁āύāϟāĻŋ āύāϝāĻŧāĨ¤
  • āĻŽāĻžāύ āύāĻŋāϝāĻŧāĻ¨ā§āĻ¤ā§āϰāĻŖ. āĻ­āĻžāϞ⧋ āχāĻžā§āϜāĻŋāύāĻŋāϝāĻŧāĻžāϰāĻŋāĻ‚ āĻĒāĻ›āĻ¨ā§āĻĻ āĻ‰ā§ŽāĻĒāĻžāĻĻāύ⧇ āύāĻŋāĻ°ā§āĻ­āϰāϝ⧋āĻ—ā§āϝāϤāĻžāϰ āϘāϟāύāĻž āĻ•āĻŽāĻŋāϝāĻŧ⧇ āĻĻ⧇āϝāĻŧāĨ¤

āϜāĻ¨ā§āϝ āϏāϤāĻ°ā§āĻ•

  • āĻāĻ•āϟāĻŋ āĻŦ⧇āĻžā§āϚāĻŽāĻžāĻ°ā§āĻ• āĻ…āĻĒā§āϟāĻŋāĻŽāĻžāχāϜ āĻ•āϰāĻž āĻŦ⧃āĻšāĻ¤ā§āϤāϰ āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽ āĻĻ⧁āĻ°ā§āĻŦāϞāϤāĻž āφāĻĄāĻŧāĻžāϞ āĻ•āϰāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤
  • āĻ…āĻŦāĻ•āĻžāĻ āĻžāĻŽā§‹ āĻāĻŦāĻ‚ āϰāĻ•ā§āώāĻŖāĻžāĻŦ⧇āĻ•ā§āώāϪ⧇āϰ āĻ–āϰāϚ āĻĒā§āϰāĻžāϝāĻŧāχ āĻ…āĻŦāĻŽā§‚āĻ˛ā§āϝāĻžāϝāĻŧāύ āĻ•āϰāĻž āĻšāϝāĻŧāĨ¤
  • āϏāĻŋāĻ¸ā§āĻŸā§‡āĻŽāϗ⧁āϞāĻŋ āφāϰāĻ“ āϜāϟāĻŋāϞ āĻšāĻ“āϝāĻŧāĻžāϰ āϏāĻžāĻĨ⧇ āϏāĻžāĻĨ⧇ āϏ⧁āϰāĻ•ā§āώāĻž āĻāĻŦāĻ‚ āĻĒāĻ°ā§āϝāĻŦ⧇āĻ•ā§āώāĻŖāϝ⧋āĻ—ā§āϝāϤāĻžāϰ āĻĢāĻžāρāĻ• āĻŦāĻžāĻĄāĻŧāϤ⧇ āĻĒāĻžāϰ⧇āĨ¤

āĻĒāϰāĻŦāĻ°ā§āϤ⧀ āĻĒāĻĻāĻ•ā§āώ⧇āĻĒ

  1. āĻŦāĻžāĻ¸ā§āϤāĻŦāĻžāϝāĻŧāύ⧇āϰ āφāϗ⧇ āĻŦāĻŋāϞāĻŽā§āĻŦ, āϗ⧁āĻŖāĻŽāĻžāύ āĻāĻŦāĻ‚ āĻ–āϰāĻšā§‡āϰ āϞāĻ•ā§āĻˇā§āϝ āύāĻŋāĻ°ā§āϧāĻžāϰāĻŖ āĻ•āϰ⧁āύāĨ¤
  2. āĻŦāĻžāĻ¸ā§āϤāĻŦāϏāĻŽā§āĻŽāϤ āϞ⧋āĻĄ āĻāĻŦāĻ‚ āĻĄā§‡āϟāĻž āĻ…āĻŦāĻ¸ā§āĻĨāĻžāϰ āĻ…āϧ⧀āύ⧇ āĻŦ⧇āĻžā§āϚāĻŽāĻžāĻ°ā§āĻ•āĨ¤
  3. āĻ¤ā§āϰ⧁āϟāĻŋ, āĻĒā§āϰāĻŦāĻžāĻš, āĻāĻŦāĻ‚ āĻŦā§āϝāĻŦāĻšāĻžāϰāĻ•āĻžāϰ⧀āϰ āĻĒā§āϰāĻ­āĻžāĻŦ⧇āϰ āϜāĻ¨ā§āϝ āϝāĻ¨ā§āĻ¤ā§āϰ āĻĒāĻ°ā§āϝāĻŦ⧇āĻ•ā§āώāĻŖāĨ¤
  4. āĻ¸ā§āϕ⧇āϞ āĻ•āϰāĻžāϰ āφāϗ⧇ āϰ⧋āϞāĻŦā§āϝāĻžāĻ• āĻāĻŦāĻ‚ āϘāϟāύāĻžāϰ āĻĒā§āϰāϤāĻŋāĻ•ā§āϰāĻŋāϝāĻŧāĻž āĻĒāĻžāĻĨ āĻĒā§āϰāĻ¸ā§āϤ⧁āϤ āĻ•āϰ⧁āύāĨ¤

āĻ…āĻ¨ā§āĻŦ⧇āώāĻŖ āϚāĻžāϞāĻŋāϝāĻŧ⧇ āϝāĻžāύ

āĻĢā§āϰāĻŋ āύāĻŋāωāϜāϞ⧇āϟāĻžāϰ

āĻĒā§āϰāϤāĻŋāĻĻāĻŋāύ⧇āϰ āĻāφāχ āĻŦā§āϰāĻŋāĻĢāĻŋāĻ‚ āĻĒāĻžāύ

āĻĒā§āϰāϤāĻŋ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āĻ•āĻžāĻœā§‡āϰ āĻĻāĻŋāύ āϏāĻ•āĻžāϞ⧇ āϤāĻŋāύāϟāĻŋ āϝāĻžāϚāĻžāχāĻ•ā§ƒāϤ āĻāφāχ āĻ¸ā§āĻŸā§‹āϰāĻŋ, āϏāĻšāϜ āχāĻ‚āϰ⧇āϜāĻŋāϤ⧇ āϞ⧇āĻ–āĻžāĨ¤ āϚāĻŋāϰāĻ•āĻžāϞ⧇āϰ āϜāĻ¨ā§āϝ āĻĢā§āϰāĻŋ, āϕ⧋āύ⧋ āĻŦāĻŋāĻœā§āĻžāĻžāĻĒāύ āύ⧇āχāĨ¤

āĻĒā§āϰāϤāĻŋ āϏāĻĒā§āϤāĻžāĻšā§‡āϰ āĻ•āĻžāĻœā§‡āϰ āĻĻāĻŋāύ⧇ āĻāĻ•āϟāĻŋ āχāĻŽā§‡āϞāĨ¤ āĻāĻ• āĻ•ā§āϞāĻŋāϕ⧇āχ āφāύāϏāĻžāĻŦāĻ¸ā§āĻ•ā§āϰāĻžāχāĻŦ āĻ•āϰ⧁āύāĨ¤ āφāĻŽāϰāĻž āĻ•āĻ–āύ⧋āχ āφāĻĒāύāĻžāϰ āĻ āĻŋāĻ•āĻžāύāĻž āĻŦāĻŋāĻ•ā§āϰāĻŋ āĻŦāĻž āĻļā§‡ā§ŸāĻžāϰ āĻ•āϰāĻŋ āύāĻžāĨ¤

āύāĻŋāĻœā§‡āϕ⧇ āĻĒāϰ⧀āĻ•ā§āώāĻž āĻ•āϰ⧁āύ

Take the TRIPOD+AI and CONSORT-AI Reporting Guidelines quiz

āĻĒā§āϰāϤāĻŋāϟāĻŋ āωāĻ¤ā§āϤāϰ⧇āϰ āϤāĻžā§ŽāĻ•ā§āώāĻŖāĻŋāĻ• āĻĢāĻŋāĻĄāĻŦā§āϝāĻžāĻ•, āĻāĻŦāĻ‚ āϕ⧋āĻ°ā§āϏ āĻĒāĻžāϏ āĻ•āϰāĻžāϰ āĻĒāϰ āϝāĻžāϚāĻžāχāϝ⧋āĻ—ā§āϝ āφāχāĻĄāĻŋ āϏāĻš āĻāĻ•āϟāĻŋ āĻļā§‡ā§ŸāĻžāϰāϝ⧋āĻ—ā§āϝ āϏāĻžāĻ°ā§āϟāĻŋāĻĢāĻŋāϕ⧇āϟāĨ¤

āϕ⧁āχāϜ āĻļ⧁āϰ⧁ āĻ•āϰ⧁āύ

āĻĢā§āϰāĻŋ āĻāφāχ āĻļāĻŋāĻ•ā§āώāĻžāϕ⧇ āϏāĻŽāĻ°ā§āĻĨāύ āĻ•āϰ⧁āύāĨ¤ AI Understanding āĻāĻ•āϟāĻŋ 501(c)(3) āĻ…āϞāĻžāĻ­āϜāύāĻ• āĻĒā§āϰāϤāĻŋāĻˇā§āĻ āĻžāύ — āϕ⧋āύ⧋ āĻŦāĻŋāĻœā§āĻžāĻžāĻĒāύ āύ⧇āχ, āϕ⧋āύ⧋ āĻĒ⧇āĻ“ā§ŸāĻžāϞ āύ⧇āχ, āĻ•āĻ–āύ⧋āχ āύāĻžāĨ¤ āĻāĻ•āϟāĻŋ āĻĻāĻžāύ āĻ•āϰ⧁āύ

āĻĒā§āϰāĻžāϝāĻŧāĻļāχ āϜāĻŋāĻœā§āĻžāĻžāϏāĻŋāϤ āĻĒā§āϰāĻļā§āύāĻžāĻŦāϞ⧀

What is TRIPOD+AI and CONSORT-AI Reporting Guidelines?

TRIPOD+AI and CONSORT-AI are reporting guidelines that help researchers describe prediction-model studies and clinical trials involving AI. They improve transparency and interpretability but do not certify study quality or prove a model is safe. Authors should match the guideline to study design and report intended use, data, methods, and AI-specific details.

Do reporting checklists prove a model is safe?

Reporting completeness is not proof of safety or effectiveness.

What should a prediction-model report describe?

These details let readers understand model development and evaluation.

Why report human-AI interaction in an AI trial?

Trial effects depend on how people interact with the system.

āĻļāĻŋāĻ–āϤ⧇ āĻĨāĻžāϕ⧁āύ

āϏāĻŽā§āĻĒāĻ°ā§āĻ•āĻŋāϤ āĻ—āĻžāχāĻĄ

āĻāχ āĻŦāĻŋāώāϝāĻŧ⧇āϰ āϜāĻ¨ā§āϝ āĻŦāĻžāĻ›āĻžāχ āĻ•āϰāĻž āφāϰāĻ“ āĻ—āĻžāχāĻĄ

āĻāĻ•āϟāĻŋ āĻŦāĻŋāύāĻžāĻŽā§‚āĻ˛ā§āϝ⧇ AI āĻļāĻ‚āϏāĻžāĻĒāĻ¤ā§āϰ āĻĒāĻžāύāĻāĻ•āϟāĻŋ āϏāĻ‚āĻ•ā§āώāĻŋāĻĒā§āϤ āĻŦāĻŋāύāĻžāĻŽā§‚āĻ˛ā§āϝ⧇ āϕ⧋āĻ°ā§āϏ āĻāĻŦāĻ‚ āĻĒāϰ⧀āĻ•ā§āώāĻž. āϕ⧋āύ⧋ āĻ–āϰāϚ āύ⧇āχ, āϕ⧋āύ⧋ āĻ•āĻžāĻ°ā§āĻĄ āύ⧇āχāĨ¤ āĻĒā§āϰāĻžāϝāĻŧ 2.5 āϘāĻ¨ā§āϟāĻžāĨ¤āĻŦāĻŋāύāĻžāĻŽā§‚āĻ˛ā§āϝ⧇ āĻļ⧁āϰ⧁ āĻ•āϰ⧁āύ →